| Authors | Lee Ratner, Thomas A Waldmann, Murali Janakiram, Jonathan E Brammer |
| Journal | The New England journal of medicine
(N Engl J Med)
Vol. 378
Issue 20
Pg. 1947-1948
(May 17 2018)
ISSN: 1533-4406 [Electronic] United States |
| PMID | 29768155
(Publication Type: Clinical Trial, Phase II, Letter)
|
| Chemical References |
- Antibodies, Monoclonal
- Antineoplastic Agents
- Programmed Cell Death 1 Receptor
- Nivolumab
|
| Topics |
- Antibodies, Monoclonal
(adverse effects, therapeutic use)
- Antineoplastic Agents
(adverse effects, therapeutic use)
- Disease Progression
- Humans
- Leukemia-Lymphoma, Adult T-Cell
(drug therapy)
- Nivolumab
- Programmed Cell Death 1 Receptor
(antagonists & inhibitors)
|
